<DOC>
	<DOCNO>NCT02934659</DOCNO>
	<brief_summary>The primary objective pilot study collect data safety effectiveness Atlas Knee System subject medial knee osteoarthritis 24 month postoperative follow-up .</brief_summary>
	<brief_title>Atlas Knee System Clinical System Clinical Study ( USA )</brief_title>
	<detailed_description>This study design prospective , multicenter , open-label , single arm , pilot study . Eligible subject symptomatic osteoarthritis medial compartment knee enrol study receive Atlas Knee Implant . The study population consist adult subject age 25 80 year , diagnosis medial knee osteoarthritis ( Kellgen Lawrence Grades 1-4 , except bony erosion ) pain study knee demonstrate overall WOMAC pain score ≥ 40 ( scale 0-100 ) .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Male female subject age 25 80 year time screen 2 . Clinical symptom ( pain primarily localize medial aspect knee generally exacerbate weight bearing ) radiographic evidence osteoarthritis medial compartment knee Weightbearing Fixed Flexion view recommend verify radiographic evidence osteoarthritis KL Grade 14 , except bony erosion 3 . Has pain study knee demonstrate minimum score 40 ( scale 0100 ) WOMAC pain question KOOS 4 . Has fail least six ( 6 ) month nonoperative treatment continue osteoarthritis ( OA ) pain . Prior treatment define treatment least one follow intervention ( list AAOS Clinical Practice Guidelines Treatment Osteoarthritis Knee Nonarthroplasty ) : Lifestyle modification Weight loss , BMI ≥35 Pain reliever Physical Therapy Orthotics ( Splints , Braces ) IntraArticular ( IA ) corticosteroid injection . 5 . Knee flexion ≥90⁰ 6 . Body Mass Index ( BMI ) &lt; 35 weight &lt; 300 lb . 7 . Subjects able give voluntary write informed consent participate clinical investigation 8 . Subjects , , opinion Clinical Investigator , able understand clinical investigation , cooperate investigational procedure , willing return require posttreatment follow visit . 1 . Clinical symptom radiographic evidence osteoarthritis lateral compartment study knee define Kellgren &amp; Lawrence ( K &amp; L ) grade &gt; 1 2 . Clinical symptom radiographic evidence osteoarthritis patellafemoral compartment study knee define K &amp; L grade ≥ 3 3 . Clinical symptom radiographic evidence osteoarthritis contralateral knee would preclude activity daily living , stair climbing , stair descending , require use assist device 4 . Tibialfemoral alignment 10⁰ varus , 6⁰ valgus , measure use anatomical axis stand HipKneeAnkle long stand AP view Xray OR HipKneeAnkle alignment 16⁰ varus , 0⁰ valgus , measure use mechanical axis stand HipKneeAnkle AP view xray 5 . Previous joint modifying surgery study knee within 12 month prior plan surgery date ligament reconstruction , meniscus repair , cartilage transplantation , microfracture 6 . Arthroscopic surgery joint lavage , meniscectomy , chondral debridement , loose body removal exclude within 3 month prior plan surgery date ; 7 . Active infection , sepsis , osteomyelitis history septic arthritis joint ; 8 . Previous lateral meniscectomy &gt; 30 % study knee 9 . Previous patellar surgery study knee 10 . Previous osteotomy fail knee joint replacement study knee 11 . Hyperextension &gt; 5⁰ 12 . Flexion contracture &gt; 10⁰ 13 . Pathologic ligamentous meniscal instability ( Lachman &gt; 1 ) assess Investigator ; 14 . Suspected document allergy hypersensitivity cobalt , chromium , iron , nickel metal ; 15 . Rheumatoid arthritis , form inflammatory joint disease autoimmune disorder ; 16 . Paget 's disease metabolic disorder may impair bone formation ; 17 . Known suspected diagnosis Osteomalacia ; 18 . Known suspected diagnosis Osteonecrosis ; 19 . Rapid joint destruction , mark bone loss bone resorption apparent xray ; 20 . Osteoporosis radiolucency femoral tibial cortex xray suggestive moderate severe osteoporosis , pathologic fracture , bone mineral density T score &gt; 2.5 Standard Deviation ( SD ) young adult reference mean ( subject screen risk osteoporosis use validated Osteoporosis SelfAssessment Tool ( OST ) score , subject high risk undergo DEXA scan determine eligibility ; 21 . Charcot 's joint disease severe neurosensory deficit ; 22 . Vascular insufficiency , muscular atrophy , neuromuscular disease ; 23 . Immunologically suppress immunocompromised ; 24 . History systemic steroid treatment , medication use affect bone metabolism ( chemotherapy ) within previous 6 month , radiotherapy within previous 6 month 25 . Any significant medical condition include : Diabetes mellitus require daily insulin therapy Neuropathic pain fibromyalgia , knee pain require chronic pain management Advanced liver kidney disease Congestive heart failure Uncontrolled transient ischemic attack Cancer HIV ( immunocompromised subject ) Radicular symptom associate lumbar spine pathology Neurological disorder result gait disturbance Restless leg syndrome History complex regional pain syndrome ( Reflex Sympathetic Dystrophy ( RSD ) ; l. Significant psychiatric disorder ( major depression , anxiety disorder , bipolar disorder , schizophrenia ) ; m. History active substance alcohol dependence abuse ( meet standard diagnostic criterion describe Diagnostic Statistical Manual Mental Disorders DSMIV ) 26 . Other factor investigator feel would interfere participation completion study : Planned relocation Litigation worker compensation musculoskeletal injury disorder Uncooperative subject Or reason . 27 . Pregnancy plan become pregnant 28 . Subjects currently involve investigational drug device trial enrol trial within last 3 month 29 . Prisoners ward state .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>